Two Sigma Advisers’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-63,300
| Closed | -$960K | – | 2646 |
|
|
2019
Q4 | $960K | Sell |
63,300
-16,200
| -20% | -$140K | ﹤0.01% | 1595 |
|
|
2019
Q3 | $508K | Sell |
79,500
-88,000
| -53% | -$735K | ﹤0.01% | 1705 |
|
|
2019
Q2 | $1.6M | Buy |
167,500
+43,300
| +35% | +$466K | ﹤0.01% | 1311 |
|
|
2019
Q1 | $1.68M | Buy |
124,200
+8,800
| +8% | +$73.4K | ﹤0.01% | 1296 |
|
|
2018
Q4 | $830K | Sell |
115,400
-75,200
| -39% | -$823K | ﹤0.01% | 1572 |
|
|
2018
Q3 | $2.08M | Sell |
190,600
-19,000
| -9% | -$192K | 0.01% | 1212 |
|
|
2018
Q2 | $1.93M | Buy |
209,600
+138,700
| +196% | +$1.29M | 0.01% | 1316 |
|
|
2018
Q1 | $566K | Buy |
70,900
+62,900
| +786% | +$1.37M | ﹤0.01% | 1769 |
|
|
2017
Q4 | $222K | Buy |
+8,000
| New | +$212K | ﹤0.01% | 2057 |
|
|
2016
Q4 | – | Sell |
-24,600
| Closed | -$832K | – | 2502 |
|
|
2016
Q3 | $832K | Buy |
24,600
+9,500
| +63% | +$306K | ﹤0.01% | 1446 |
|
|
2016
Q2 | $442K | Buy |
+15,100
| New | +$417K | ﹤0.01% | 1571 |
|
Two Sigma Advisers's DERM Position: Q1 2020 in Review
Two Sigma Advisers sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 63,300 shares — an estimated $960K sold.
Two Sigma Advisers first reported a position in DERM in Q2 2016 and held it in 11 quarters. The position peaked at $2.08M in Q3 2018. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Two Sigma Advisers reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Two Sigma Advisers sold 63,300 Dermira, Inc. shares in Q1 2020, an estimated $960K.
- Two Sigma Advisers first reported a position in Dermira, Inc. in Q2 2016 and held it in 11 quarters.
- Two Sigma Advisers's Dermira, Inc. position peaked at $2.08M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Two Sigma Advisers's 13F filing for Q1 2020, filed 15 May 2020.